HSP40 Heat-Shock Proteins
"HSP40 Heat-Shock Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A family of heat-shock proteins that contain a 70 amino-acid consensus sequence known as the J domain. The J domain of HSP40 heat shock proteins interacts with HSP70 HEAT-SHOCK PROTEINS. HSP40 heat-shock proteins play a role in regulating the ADENOSINE TRIPHOSPHATASES activity of HSP70 heat-shock proteins.
| Descriptor ID |
D050956
|
| MeSH Number(s) |
D12.776.580.216.292
|
| Concept/Terms |
HSP40 Heat-Shock Proteins- HSP40 Heat-Shock Proteins
- HSP40 Heat Shock Proteins
- Heat-Shock Proteins, HSP40
- Proteins, HSP40 Heat-Shock
- Heat Shock Protein 40 Family
- Heat-Shock Protein 40
- Heat Shock Protein 40
- HSP40 Proteins
- DnaJ Proteins
- HSP40 Protein Family
- Heat-Shock Proteins 40
- Heat Shock Proteins 40
|
Below are MeSH descriptors whose meaning is more general than "HSP40 Heat-Shock Proteins".
Below are MeSH descriptors whose meaning is more specific than "HSP40 Heat-Shock Proteins".
This graph shows the total number of publications written about "HSP40 Heat-Shock Proteins" by people in this website by year, and whether "HSP40 Heat-Shock Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HSP40 Heat-Shock Proteins" by people in Profiles.
-
Robinson RM, Basar AP, Reyes L, Duncan RM, Li H, Dolloff NG. PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma. Cancer Chemother Pharmacol. 2022 05; 89(5):643-653.
-
Duncan RM, Reyes L, Moats K, Robinson RM, Murphy SA, Kaur B, Stessman HAF, Dolloff NG. ATF3 Coordinates Antitumor Synergy between Epigenetic Drugs and Protein Disulfide Isomerase Inhibitors. Cancer Res. 2020 08 15; 80(16):3279-3291.
-
Lancet JE, Gojo I, Gotlib J, Feldman EJ, Greer J, Liesveld JL, Bruzek LM, Morris L, Park Y, Adjei AA, Kaufmann SH, Garrett-Mayer E, Greenberg PL, Wright JJ, Karp JE. A phase 2 study of the farnesyltransferase inhibitor tipifarnib in poor-risk and elderly patients with previously untreated acute myelogenous leukemia. Blood. 2007 Feb 15; 109(4):1387-94.
-
Yang W, Hildebrandt JD. Genomic analysis of G protein gamma subunits in human and mouse - the relationship between conserved gene structure and G protein betagamma dimer formation. Cell Signal. 2006 Feb; 18(2):194-201.
-
Zzaman S, Reddy JM, Bastia D. The DnaK-DnaJ-GrpE chaperone system activates inert wild type pi initiator protein of R6K into a form active in replication initiation. J Biol Chem. 2004 Dec 03; 279(49):50886-94.
-
Miller SL, Malotky E, O'Bryan JP. Analysis of the role of ubiquitin-interacting motifs in ubiquitin binding and ubiquitylation. J Biol Chem. 2004 Aug 06; 279(32):33528-37.